Table 3.
β (95% CI) | Adjusted βa (95% CI) | P-value | |
---|---|---|---|
Clinical assessment | |||
Prior duration, days | 0.07 (0.01 to 0.13) | 0.10 (0.04 to 0.15) | 0.001b |
History of fever | 0.51 (−0.34 to 1.36) | −0.03 (−0.86 to 0.80) | 0.95 |
Green-coloured sputum | 0.26 (−0.56 to 1.07) | 0.16 (−0.61 to 0.94) | 0.68 |
Sore throat | −0.03 (−0.91 to 0.84) | −0.14 (−0.97 to 0.69) | 0.74 |
Runny nose | −0.55 (−1.42 to 0.33) | −0.61 (−1.42 to 0.20) | 0.14 |
Prolonged expiration | 1.32 (−1.41 to 4.05) | 0.73 (−1.79 to 3.25) | 0.57 |
Respiration rate, ≥20/min | −0..08 (−1.05 to 0.88) | 0.02 (−1.05 to 0.26) | 0.97 |
Temperature, ≥37.0°C | −0.68 (−1.55 to 0.20) | −0.86 (−1.68 to −0.04) | 0.04 |
Coarse crepitations | −0.03 (−1.17 to 1.10) | −0.02 (−1.09 to −1.04) | 0.96 |
Wheeze | −0.07 (−1.32 to 1.17) | −0.14 (−1.31 to 1.03) | 0.82 |
Fine crepitations | −0.87 (−3.32 to 1.58) | −0.18 (−2.51 to 2.16) | 0.88 |
Smoker | −0.13 (−1.29 to 1.04) | −0.08 (−1.19 to 1.02) | 0.88 |
Age | |||
Older age, ≥60 years | −1.52 (−2.59 to 0.45) | −0.81 (−1.83 to 0.20) | 0.12 |
Children, <16 years | −0.72 (−1.82 to 0.37) | −0.20 (−1.25 to 0.85) | 0.71 |
Symptoms on day 1 | |||
Cough | 1.04 (0.69 to 1.39) | 0.68 (0.30 to 1.05) | <0.001b |
Sputum | 0.58 (0.32 to 0.85) | 0.21 (−0.07 to 0.48) | 0.14 |
Short of breath | 0.52 (0.25 to 0.78) | 0.06 (−0.23 to 0.34) | 0.69 |
Sleep | 0.63 (0.38 to 0.89) | 0.11 (−0.17 to 0.40) | 0.43 |
Restriction of activities | 0.91 (0.65 to 1.17) | 0.82 (0.54 to 1.11) | <0.001b |
Unwell | 0.89 (0.61 to 1.16) | 0.21 (−0.20 to 0.63) | 0.31 |
The β estimates are the estimate of the number of days' difference in duration attributable to each variable.
The estimates for each variable controls for the effects of the other variables and the randomised interventions.
P-value is significant at ≤0.01.